Valuation — not yet established
No valuation for Intus Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($15.4M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Intus Biosciences
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Seed Round | $1.1M | ▮ | ▮ |
| Jun 2024 | Seed Round | $2.0M | ▮ | ▮ |
| Nov 2022 | Seed Round | $1.1M | ▮ | ▮ |
How Intus Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Intus Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Intus Biosciences raised?
- Intus Biosciences has raised $15.4M in total funding across 3 recorded rounds.
- When did Intus Biosciences last raise?
- Intus Biosciences last raised in May 2025 (Seed Round), raising $1.1M.